MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $372 | -27.5% | 23,170 | +4.7% | 0.00% | -33.3% |
Q2 2023 | $513 | -11.6% | 22,123 | -11.4% | 0.00% | -25.0% |
Q1 2023 | $580 | +63.4% | 24,963 | +2.2% | 0.00% | +33.3% |
Q4 2022 | $355 | -99.9% | 24,434 | -7.1% | 0.00% | -25.0% |
Q3 2022 | $502,000 | +117.3% | 26,301 | +107.2% | 0.00% | +100.0% |
Q2 2022 | $231,000 | -44.2% | 12,695 | -22.8% | 0.00% | 0.0% |
Q1 2022 | $414,000 | -1.0% | 16,448 | +8.5% | 0.00% | 0.0% |
Q4 2021 | $418,000 | +6.6% | 15,155 | +24.9% | 0.00% | 0.0% |
Q3 2021 | $392,000 | +30.2% | 12,132 | +23.4% | 0.00% | 0.0% |
Q2 2021 | $301,000 | +18.0% | 9,835 | +17.6% | 0.00% | +100.0% |
Q1 2021 | $255,000 | -32.5% | 8,362 | +1.7% | 0.00% | -66.7% |
Q3 2018 | $378,000 | -28.5% | 8,221 | -42.0% | 0.00% | 0.0% |
Q2 2018 | $529,000 | +17.0% | 14,162 | -7.4% | 0.00% | 0.0% |
Q1 2018 | $452,000 | -43.2% | 15,296 | -34.0% | 0.00% | -40.0% |
Q4 2017 | $796,000 | +290.2% | 23,165 | +311.3% | 0.01% | +400.0% |
Q3 2017 | $204,000 | -33.6% | 5,632 | -43.8% | 0.00% | -50.0% |
Q2 2016 | $307,000 | -83.7% | 10,028 | -80.1% | 0.00% | -84.6% |
Q1 2016 | $1,883,000 | -32.8% | 50,301 | -22.6% | 0.01% | -35.0% |
Q4 2015 | $2,803,000 | +778.7% | 64,949 | +662.9% | 0.02% | +566.7% |
Q3 2015 | $319,000 | +235.8% | 8,513 | +204.4% | 0.00% | +200.0% |
Q2 2015 | $95,000 | -82.0% | 2,797 | -81.3% | 0.00% | -75.0% |
Q1 2015 | $529,000 | +596.1% | 14,952 | +569.3% | 0.00% | +300.0% |
Q4 2014 | $76,000 | -24.0% | 2,234 | -13.4% | 0.00% | 0.0% |
Q3 2014 | $100,000 | -2.0% | 2,581 | -1.2% | 0.00% | 0.0% |
Q2 2014 | $102,000 | +7.4% | 2,613 | -5.9% | 0.00% | 0.0% |
Q1 2014 | $95,000 | +50.8% | 2,777 | -7.4% | 0.00% | 0.0% |
Q4 2013 | $63,000 | -74.3% | 3,000 | -71.3% | 0.00% | -50.0% |
Q3 2013 | $245,000 | +66.7% | 10,445 | +90.4% | 0.00% | +100.0% |
Q2 2013 | $147,000 | – | 5,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |